Genome stability pathways in head and neck cancers

International Journal of Genomics

Volumn 2013, Issue , 2013, Pages

  Jenkins, Glenn ^a,b   O'Byrne, Kenneth J ^b,c   Panizza, Benedict ^a,c   Richard, Derek J ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MISMATCH REPAIR PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; REPLICATION FACTOR A; TRANSFORMING GROWTH FACTOR ALPHA;

ALKYLATION; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CHROMOSOME 7; CHROMOSOME ABERRATION; DISEASE FREE SURVIVAL; DNA ADDUCT; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; EXTERNAL BEAM RADIOTHERAPY; FANCONI ANEMIA; GENE MUTATION; GENOMIC INSTABILITY; GENOTYPE; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IONIZING RADIATION; LYMPH NODE METASTASIS; META ANALYSIS (TOPIC); MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOUTH CANCER; NUCLEIC ACID BASE SUBSTITUTION; OVERALL SURVIVAL; OXIDATIVE STRESS; PERINEURAL INVASION; PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; PRECANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION PROTECTION; RECURRENCE FREE SURVIVAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; UPREGULATION; XERODERMA PIGMENTOSUM;

EID: 84889016853     PISSN: 2314436X     EISSN: 23144378     Source Type: Journal    
DOI: 10.1155/2013/464720     Document Type: Review

References (259)

1. Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010 127 12 2893 2917 2-s2.0-78049485263 10.1002/ijc.25516
2. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA: A Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
3. Maeda T., Jikko A., Hiranuma H., Fuchihata H., Analysis of genomic instability in squamous cell carcinoma of the head and neck using the random amplified polymorphic DNA method. Cancer Letters 1999 138 1-2 183 188 2-s2.0-0033606136 10.1016/S0304-3835(99)00004-X (Pubitemid 29189202)
4. Merlano M., Vitale V., Rosso R., Benasso M., Corvo R., Cavallari M., Sanguineti G., Bacigalupo A., Badellino F., Margarino G., Brema F., Pastorino G., Marziano C., Grimaldi A., Scasso F., Sperati G., Pallestrini E., Garaventa G., Accomando E., Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. The New England Journal of Medicine 1992 327 16 1115 1121 2-s2.0-0026779826
5. Pignon J.-P., Maître A. L., Maillard E., Bourhis J., Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology 2009 92 1 4 14 2-s2.0-66949128922 10.1016/j.radonc.2009.04.014
6. Furness S., Glenny A.-M., Worthington H. V., Pavitt S., Oliver R., Clarkson J. E., Macluskey M., Chan K. K., Conway D. I., Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database of Systematic Reviews 2011 4 CD006386 2-s2.0-79955651331
7. Pignon J. P., Bourhis J., Domenge C., Designé L., Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. The Lancet 2000 355 9208 949 955 2-s2.0-0034681783 (Pubitemid 30148259)
8. Logan R. M., Advances in understanding of toxicities of treatment for head and neck cancer. Oral Oncology 2009 45 10 844 848 2-s2.0-70349120913 10.1016/j.oraloncology.2009.03.018
9. Murdoch D., Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review. Current Opinion in Oncology 2007 19 3 216 221 2-s2.0-34247113309 10.1097/01.cco.0000264952.98166.99 (Pubitemid 46597480)
10. Posner M. R., Hershock D. M., Blajman C. R., Mickiewicz E., Winquist E., Gorbounova V., Tjulandin S., Shin D. M., Cullen K., Ervin T. J., Murphy B. A., Raez L. E., Cohen R. B., Spaulding M., Tishler R. B., Roth B., Viroglio R. D. C., Venkatesan V., Romanov I., Agarwala S., Harter K. W., Dugan M., Cmelak A., Markoe A. M., Read P. W., Steinbrenner L., Colevas A. D., Norris C. M. Jr., Haddad R. I., Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. The New England Journal of Medicine 2007 357 17 1705 1715 2-s2.0-35548972994 10.1056/NEJMoa070956 (Pubitemid 350005152)
11. Boveri T., Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. Journal of Cell Science 2008 121 supplement 1 1 84 2-s2.0-74049135504
12. Hakem R., DNA-damage repair; the good, the bad, and the ugly. The EMBO Journal 2008 27 4 589 605 2-s2.0-39449085063 10.1038/emboj.2008.15 (Pubitemid 351273123)
13. Gorgoulis V. G., Vassiliou L.-V. F., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., DiTullio R. A. Jr., Kastrinakis N. G., Levy B., Kletsas D., Yoneta A., Herlyn M., Kittas C., Halazonetis T. D., Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005 434 7035 907 913 2-s2.0-17244366865 10.1038/nature03485 (Pubitemid 40559004)
14. DiTullio R. A. Jr., Mochan T. A., Venere M., Bartkova J., Sehested M., Bartek J., Halazonetis T. D., 53BP1 functions in a ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nature Cell Biology 2002 4 12 998 1002 2-s2.0-0036902410 10.1038/ncb892 (Pubitemid 35469432)
15. Bartek J., Bartkova J., Lukas J., DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007 26 56 7773 7779 2-s2.0-36949005417 10.1038/sj.onc.1210881 (Pubitemid 350242463)
16. Sturgis E. M., Cinciripini P. M., Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007 110 7 1429 1435 2-s2.0-34648825016 10.1002/cncr.22963 (Pubitemid 47463055)
17. Hoffmann M., Kahn T., Mahnke C. G., Goeroegh T., Lippert B. M., Werner J. A., Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta Oto-Laryngologica 1998 118 1 138 144 2-s2.0-0031887531 10.1080/00016489850155279 (Pubitemid 28100009)
18. Termine N., Panzarella V., Falaschini S., Russo A., Matranga D., Lo Muzio L., Campisi G., HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Annals of Oncology 2008 19 10 1681 1690 2-s2.0-53049103211 10.1093/annonc/mdn372
19. Kansy K., Thiele O., Freier K., The role of human papillomavirus in oral squamous cell carcinoma: myth and reality. Oral and Maxillofacial Surgery 2012 10.1007/s10006-012-0383-0
20. Marur S., D'Souza G., Westra W. H., Forastiere A. A., HPV-associated head and neck cancer: a virus-related cancer epidemic. The Lancet Oncology 2010 11 8 781 789 2-s2.0-77955282693 10.1016/S1470-2045(10)70017-6
21. Dayyani F., Etzel C. J., Liu M., Ho C.-H., Lippman S. M., Tsao A. S., Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head and Neck Oncology 2010 2 1, article 15 2-s2.0-77954983213 10.1186/1758-3284-2-15
22. Ang K. K., Harris J., Wheeler R., Human papillomavirus and survival of patients with oropharyngeal cancer. The New England Journal of Medicine 2010 363 1 24 35 10.1056/NEJMoa0912217
23. D'Souza G., Kreimer A. R., Viscidi R., Pawlita M., Fakhry C., Koch W. M., Westra W. H., Gillison M. L., Case-control study of human papillomavirus and oropharyngeal cancer. The New England Journal of Medicine 2007 356 19 1944 1956 2-s2.0-34248350674 10.1056/NEJMoa065497 (Pubitemid 46740304)
24. D'Souza G., Agrawal Y., Halpern J., Bodison S., Gillison M. L., Oral sexual behaviors associated with prevalent oral human papillomavirus infection. Journal of Infectious Diseases 2009 199 9 1263 1269 2-s2.0-65649107617 10.1086/597755
25. Schwartz S. M., Daling J. R., Doody D. R., Wipf G. C., Carter J. J., Madeleine M. M., Mao E.-J., Fitzgibbons E. D., Huang S., Beckmann A. M., McDougall J. K., Galloway D. A., Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. Journal of the National Cancer Institute 1998 90 21 1626 1636 2-s2.0-0032483740 (Pubitemid 28523437)
26. Lassen P., Eriksen J. G., Hamilton-Dutoit S., Tramm T., Alsner J., Overgaard J., Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. Journal of Clinical Oncology 2009 27 12 1992 1998 2-s2.0-65349173893 10.1200/JCO.2008.20.2853
27. Gillison M. L., D'Souza G., Westra W., Sugar E., Xiao W., Begum S., Viscidi R., Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. Journal of the National Cancer Institute 2008 100 6 407 420 2-s2.0-41449085148 10.1093/jnci/djn025 (Pubitemid 351480511)
28. Smeets S. J., Braakhuis B. J. M., Abbas S., Snijders P. J. F., Ylstra B., Van De Wiel M. A., Meijer G. A., Leemans C. R., Brakenhoff R. H., Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006 25 17 2558 2564 2-s2.0-32644444748 10.1038/sj.onc.1209275
29. Wilting S. M., Smeets S. J., Snijders P. J., Van Wieringen W. N., Van De Wiel M. A., Meijer G. A., Ylstra B., Leemans C. R., Meijer C. J., Brakenhoff R. H., Braakhuis B. J., Steenbergen R. D., Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck. BMC Medical Genomics 2009 2 1, article 32 2-s2.0-67650766639 10.1186/1755-8794-2-32
30. Syrjanen K., Syrjanen S., Lamberg M., Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. International Journal of Oral Surgery 1983 12 6 418 424 2-s2.0-0021015451 (Pubitemid 14141093)
31. Scheffner M., Huibregtse J. M., Vierstra R. D., Howley P. M., The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993 75 3 495 505 2-s2.0-0027358723 10.1016/0092-8674(93)90384-3 (Pubitemid 23335075)
32. Thomas M., Pim D., Banks L., The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 1999 18 53 7690 7700 2-s2.0-0033552585 (Pubitemid 30052696)
33. Mietz J. A., Unger T., Huibregtse J. M., Howley P. M., The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. The EMBO Journal 1992 11 13 5013 5020 2-s2.0-0027079358 (Pubitemid 23023445)
34. Stevaux O., Dyson N. J., A revised picture of the E2F transcriptional network and RB function. Current Opinion in Cell Biology 2002 14 6 684 691 2-s2.0-0036897835 10.1016/S0955-0674(02)00388-5 (Pubitemid 35449380)
35. Harbour J. W., Dean D. C., The Rb/E2F pathway: expanding roles and emerging paradigms. Genes and Development 2000 14 19 2393 2409 2-s2.0-0034306996 10.1101/gad.813200
36. Liu X., Clements A., Zhao K., Marmorstein R., Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. Journal of Biological Chemistry 2006 281 1 578 586 2-s2.0-33644858296 10.1074/jbc.M508455200 (Pubitemid 43671221)
37. Lewis J. S. Jr., Thorstad W. L., Chernock R. D., Haughey B. H., Yip J. H., Zhang Q., El-Mofty S. K., P16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. American Journal of Surgical Pathology 2010 34 8 1088 1096 2-s2.0-77955176135 10.1097/PAS.0b013e3181e84652
38. Lindquist D., Romanitan M., Hammarstedt L., Näsman A., Dahlstrand H., Lindholm J., Onelöv L., Ramqvist T., Ye W., Munck-Wikland E., Dalianis T., Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Molecular Oncology 2007 1 3 350 355 2-s2.0-36549011250 10.1016/j.molonc.2007.08.005 (Pubitemid 350186274)
39. Schlecht N. F., Brandwein-Gensler M., Nuovo G. J., Li M., Dunne A., Kawachi N., Smith R. V., Burk R. D., Prystowsky M. B., A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Modern Pathology 2011 24 10 1295 1305 2-s2.0-80053565597 10.1038/modpathol.2011.91
40. Duensing S., Münger K., Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene 2002 21 40 6241 6248 2-s2.0-0037048297 10.1038/sj.onc.1205709
41. Duensing S., Lee L. Y., Duensing A., Basile J., Piboonniyom S.-O., Gonzalez S., Crum C. P., Münger K., The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proceedings of the National Academy of Sciences of the United States of America 2000 97 18 10002 10007 2-s2.0-0034730196
42. Duensing S., Münger K., Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. International Journal of Cancer 2004 109 2 157 162 2-s2.0-1242319406 10.1002/ijc.11691 (Pubitemid 38240914)
43. Stransky N., Egloff A. M., Tward A. D., Kostic A. D., Cibulskis K., Sivachenko A., Kryukov G. V., Lawrence M. S., Sougnez C., McKenna A., Shefler E., Ramos A. H., Stojanov P., Carter S. L., Voet D., Cortés M. L., Auclair D., Berger M. F., Saksena G., Guiducci C., Onofrio R. C., Parkin M., Romkes M., Weissfeld J. L., Seethala R. R., Wang L., Rangel-Escareño C., Fernandez-Lopez J. C., Hidalgo-Miranda A., Melendez-Zajgla J., Winckler W., Ardlie K., Gabriel S. B., Meyerson M., Lander E. S., Getz G., Golub T. R., Garraway L. A., Grandis J. R., The mutational landscape of head and neck squamous cell carcinoma. Science 2011 333 6046 1157 1160 2-s2.0-80052158097 10.1126/science.1208130
44. Edwards T. G., Helmus M. J., Koeller K., Bashkin J. K., Fisher C., Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways. Journal of Virology 2013 87 7 3979 3989 10.1128/JVI.03473-12
45. Rieckmann T., Tribius S., Grob T. J., Meyer F., Busch C. J., Petersen C., Dikomey E., Kriegs M., HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiotherapy and Oncology 2013 107 2 242 246
46. Yakushiji T., Uzawa K., Shibahara T., Noma H., Tanzawa H., Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. International Journal of Oncology 2003 22 6 1201 1207 2-s2.0-0041627372
47. Reed A. L., Califano J., Cairns P., Westra W. H., Jones R. M., Koch W., Ahrendt S., Eby Y., Sewell D., Nawroz H., Bartek J., Sidransky D., High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Research 1996 56 16 3630 3633 2-s2.0-9444255067 (Pubitemid 26272001)
48. Tsai C.-H., Yang C.-C., Chou L. S.-S., Chou M.-Y., The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 2001 30 9 527 531 2-s2.0-0034794887 10.1034/j.1600-0714.2001.300903.x (Pubitemid 32943808)
49. Pande P., Mathur M., Shukla N. K., Ralhan R., pRB and p16 protein alterations in human oral tumorigenesis. Oral Oncology 1998 34 5 396 403 2-s2.0-0032167474 10.1016/S1368-8375(98)00024-4 (Pubitemid 28440304)
50. Duray A., Descamps G., Decaestecker C., Remmelink M., Sirtaine N., Lechien J., Ernoux-Neufcoeur P., Bletard N., Somja J., Depuydt C. E., Delvenne P., Saussez S., Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 2012 122 7 1558 1565 2-s2.0-84859936200 10.1002/lary.23298
51. Ernoux-Neufcoeur P., Arafa M., Decaestecker C., Duray A., Remmelink M., Leroy X., Herfs M., Somja J., Depuydt C. E., Delvenne P., Saussez S., Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology 2011 137 1 173 181 2-s2.0-78751611207 10.1007/s00432-010-0871-2
52. Marsit C. J., Christensen B. C., Houseman E. A., Karagas M. R., Wrensch M. R., Yeh R.-F., Nelson H. H., Wiemels J. I., Zheng S., Posner M. R., Mcclean M. D., Wiencke J. K., Kelsey K. T., Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 2009 30 3 416 422 2-s2.0-62349119224 10.1093/carcin/bgp006
53. Merlo A., Herman J. G., Mao L., Lee D. J., Gabrielson E., Burger P. C., Baylin S. B., Sidransky D., 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine 1995 1 7 686 692 2-s2.0-0029011539
54. Abou-Elhamd K.-E. A., Habib T. N., The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma. Oral Oncology 2007 43 4 366 372 2-s2.0-33947185860 10.1016/j.oraloncology.2006. 04.005 (Pubitemid 46413984)
55. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., Corio R., Lee D., Greenberg B., Koch W., Sidransky D., Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Research 1996 56 11 2488 2492 2-s2.0-9344247476 (Pubitemid 26170679)
56. Bockmühl U., Wolf G., Schmidt S., Schwendel A., Jahnke V., Dietel M., Petersen I., Genomic alterations associated with malignancy in head and neck cancer. Head & Neck 1998 20 2 145 151 (Pubitemid 28106227)
57. Kiaris H., Spanakis N., Ergazaki M., Sourvinos G., Spandidos D. A., Loss of heterozygosity at 9p and 17q in human laryngeal tumours. Cancer Letters 1995 97 1 129 134 2-s2.0-0028881779 10.1016/0304-3835(95)03963-W
58. Cairns P., Polascik T. J., Eby Y., Tokino K., Califano J., Merlo A., Mao L., Herath J., Jenkins R., Westra W., Rutter J. L., Buckler A., Gabrielson E., Tockman M., Cho K. R., Hedrick L., Bova G. S., Isaacs W., Sidransky D., Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genetics 1995 11 2 210 212 2-s2.0-0029091503
59. van der Riet P., Nawroz H., Hruban R. H., Corio R., Tokino K., Koch W., Sidransky D., Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Research 1994 54 5 1156 1158 2-s2.0-0028278720 (Pubitemid 24108049)
60. Rosin M. P., Cheng X., Poh C., Lam W. L., Huang Y., Lovas J., Berean K., Epstein J. B., Priddy R., Le N. D., Zhang L., Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clinical Cancer Research 2000 6 2 357 362 2-s2.0-0033975644 (Pubitemid 30111451)
61. Soder A. I., Hopman A. H. N., Ramaekers F. C. S., Conradt C., Bosch F. X., Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Research 1995 55 21 5030 5037 2-s2.0-0028840534
62. Lydiatt W. M., Murty V. V. V. S., Davidson B. J., Xu L., Dyomina K., Sacks P. G., Schantz S. P., Chaganti R. S. K., Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors. Genes, Chromosomes and Cancer 1995 13 2 94 98 2-s2.0-0029034268 10.1002/gcc.2870130204
63. Yu K. K., Zanation A. M., Moss J. R., Yarbrough W. G., Familial head and neck cancer: molecular analysis of a new clinical entity. Laryngoscope 2002 112 9 1587 1593 2-s2.0-0036729675 (Pubitemid 34977559)
64. Cabanillas R., Astudillo A., Valle M., de la Rosa J., Álvarez R., Durán N. S., Cadiñanos J., Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas. Head and Neck 2013 35 3 E80 E84 2-s2.0-81055148171 10.1002/hed.21911
65. Maestro R., Gasparotto D., Vukosavljevic T., Barzan L., Sulfaro S., Boiocchi M., Three discrete regions of deletion at 3p in head and neck cancers. Cancer Research 1993 53 23 5775 5779 2-s2.0-0027453998 (Pubitemid 23360286)
66. Hogg R. P., Honorio S., Martinez A., Agathanggelou A., Dallol A., Fullwood P., Weichselbaum R., Kuo M. J., Maher E. R., Latif F., Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. European Journal of Cancer 2002 38 12 1585 1592 2-s2.0-0036342284 10.1016/S0959-8049(01)00422-1 (Pubitemid 34879144)
67. Uzawa N., Yoshida M. A., Hosoe S., Oshimura M., Amagasa T., Ikeuchi T., Functional evidence for involvement of multiple putative tumor suppressor genes on the short arm of chromosome 3 in human oral squamous cell carcinogenesis. Cancer Genetics and Cytogenetics 1998 107 2 125 131 2-s2.0-0032400889 10.1016/S0165-4608(98)00097-1 (Pubitemid 28553117)
68. Dasgupta S., Mukherjee N., Roy S., Roy A., Sengupta A., Roychowdhury S., Panda C. K., Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population. Oral Oncology 2002 38 1 6 15 2-s2.0-0036149058 10.1016/S1368- 8375(00)00131-7 (Pubitemid 34076567)
69. Tai S.-K., Lee J. I., Ang K. K., El-Naggar A. K., Hassan K. A., Liu D., Lee J. J., Ren H., Hong W. K., Mao L., Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication. Clinical Cancer Research 2004 10 16 5554 5557 2-s2.0-4143070299 10.1158/1078-0432.CCR-04-0208 (Pubitemid 39100495)
70. Ghosh S., Ghosh A., Maiti G. P., Alam N., Roy A., Roy B., Roychoudhury S., Panda C. K., Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: correlation with progression and prognosis. International Journal of Cancer 2008 123 11 2594 2604 2-s2.0-57349176947 10.1002/ijc.23834
71. Blons H., Radicella J. P., Laccourreye O., Brasnu D., Beaune P., Boiteux S., Laurent-Puig P., Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer. Molecular Carcinogenesis 1999 26 4 254 260 2-s2.0-0032759236
72. Fan C.-Y., Liu K. L., Huang H. Y., Barnes E. L., Swalsky P. A., Bakker A., Woods J., Finkelstein S. D., Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma. Laboratory Investigation 2001 81 10 1429 1438 2-s2.0-0034780112 (Pubitemid 32980165)
73. David S. S., O'Shea V. L., Kundu S., Base-excision repair of oxidative DNA damage. Nature 2007 447 7147 941 950 2-s2.0-34250900982 10.1038/nature05978 (Pubitemid 46975761)
74. Eisenstadt E., Warren A. J., Porter J., Atkins D., Miller J. H., Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proceedings of the National Academy of Sciences of the United States of America 1982 79 6 1945 1949 2-s2.0-0000956724 (Pubitemid 12088545)
75. Bernelot-Moens C., Glickman B. W., Gordon A. J. E., Induction of specific frameshift and base substitution events by benzo[a]pyrene diol expoxide in excision-repair-deficient Escherichia coli. Carcinogenesis 1990 11 5 781 785 2-s2.0-0025271437 (Pubitemid 20150245)
76. Shibutani S., Takeshita M., Grollman A. P., Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991 349 6308 431 434 2-s2.0-0025981359 10.1038/349431a0 (Pubitemid 21926107)
77. Blons H., Laurent-Puig P., TP53 and head and neck neoplasms. Human Mutation 2003 21 3 252 257 2-s2.0-0037217583 10.1002/humu.10171 (Pubitemid 36292966)
78. Yoon J.-H., Smith L. E., Feng Z., Tang M.-S., Lee C.-S., Pfeifer G. P., Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Research 2001 61 19 7110 7117 2-s2.0-0035477426 (Pubitemid 32946502)
79. Bockmühl U., Petersen S., Schmidt S., Wolf G., Jahnke V., Dietel M., Petersen I., Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Research 1997 57 23 5213 5216 2-s2.0-0030715089 (Pubitemid 27516350)
80. Bockmühl U., Schlüns K., Schmidt S., Matthias S., Petersen I., Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes, Chromosomes and Cancer 2002 33 1 29 35
81. Bockmühl U., Ishwad C. S., Ferrell R. E., Gollin S. M., Association of 8p23 deletions with poor survival in head and neck cancer. Otolaryngology-Head and Neck Surgery 2001 124 4 451 455 2-s2.0-0035321540 10.1067/mhn.2001.114794 (Pubitemid 33587110)
82. Toomes C., Jackson A., Maguire K., Wood J., Gollin S., Ishwad C., Paterson I., Prime S., Parkinson K., Bell S., Woods G., Markham A., Oliver R., Woodward R., Sloan P., Dixon M., Read A., Thakker N., The presence of multiple regions of homozygous deletion at the CSMDI locus in oral squamous cell carcinoma question the role of CSMDI in head and neck carcinogenesis. Genes, Chromosomes and Cancer 2003 37 2 132 140 2-s2.0-0038070458 10.1002/gcc.10191 (Pubitemid 36529780)
83. Papadimitrakopoulou V. A., Oh Y., El-Naggar A., Izzo J., Clayman G., Mao L., Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Clinical Cancer Research 1998 4 3 539 544 2-s2.0-0031946721 (Pubitemid 28193551)
84. Nawroz H., van der Riet P., Hruban R. H., Koch W., Ruppert J. M., Sidransky D., Allelotype of head and neck squamous cell carcinoma. Cancer Research 1994 54 5 1152 1155 2-s2.0-0028350523 (Pubitemid 24108048)
85. van Dyke D. L., Worsham M. J., Benninger M. S., Krause C. J., Baker S. R., Wolf G. T., Drumheller T., Tilley B. C., Carey T. E., Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes, Chromosomes and Cancer 1994 9 3 192 206 2-s2.0-0028269349 (Pubitemid 24074737)
86. Mertens F., Johansson B., Höglund M., Mitelman F., Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Research 1997 57 13 2765 2780 2-s2.0-0030825508 (Pubitemid 27283792)
87. Pershouse M. A., El-Naggar A. K., Hurr K., Lin H., Yung W. K. A., Steck P. A., Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene 1997 14 3 369 373 2-s2.0-0031036846 (Pubitemid 27073092)
88. Yoo G. H., Xu H.-J., Brennan J. A., Westra W., Hruban R. H., Koch W., Benedict W. F., Sidransky D., Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Research 1994 54 17 4603 4606 2-s2.0-0028017632 (Pubitemid 24276480)
89. Feenstra M., Veltkamp M., Van Kuik J., Wiertsema S., Slootweg P., Van den Tweel J., De Weger R., Tilanus M., HLA class 1 expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 1999 54 3 235 245 2-s2.0-0032586280 10.1034/j.1399-0039.1999.540304.x (Pubitemid 29443843)
90. Arlt M. F., Durkin S. G., Ragland R. L., Glover T. W., Common fragile sites as targets for chromosome rearrangements. DNA Repair 2006 5 9-10 1126 1135 2-s2.0-33748623634 10.1016/j.dnarep.2006.05.010 (Pubitemid 44376448)
91. Mizuno K., Miyabe I., Schalbetter S., Carr A. M., Murray J. M., Recombination-restarted replication makes inverted chromosome fusions at inverted repeats. Nature 2013 493 7431 246 249
92. Lieber M. R., NHEJ and its backup pathways in chromosomal translocations. Nature Structural and Molecular Biology 2010 17 4 393 395 2-s2.0-77950466186 10.1038/nsmb0410-393
93. Ferguson D. O., Alt F. W., DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene 2001 20 40 5572 5579 2-s2.0-0035839840 10.1038/sj.onc.1204767 (Pubitemid 32928098)
94. Scully C., Field J. K., Tanzawa H., Genetic aberrations in oral or head and neck squamous cell carcinoma. 2: chromosomal aberrations. Oral Oncology 2000 36 4 311 327 2-s2.0-0033933721 10.1016/S1368-8375(00)00021-X (Pubitemid 30427251)
95. Patmore H. S., Cawkwell L., Stafford N. D., Greenman J., Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review. Annals of Surgical Oncology 2005 12 10 831 842 2-s2.0-25144458940 10.1245/ASO.2005.09.017 (Pubitemid 41355936)
96. Lindahl T., Barnes D. E., Repair of endogenous DNA damage. Cold Spring Harbor Symposia on Quantitative Biology 2000 65 127 133 2-s2.0-0034437639 (Pubitemid 32611934)
97. Vilenchik M. M., Knudson A. G., Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. Proceedings of the National Academy of Sciences of the United States of America 2003 100 22 12871 12876 2-s2.0-0242300088 10.1073/pnas.2135498100 (Pubitemid 37339992)
98. Rich T., Allen R. L., Wyllie A. H., Defying death after DNA damage. Nature 2000 407 6805 777 783 2-s2.0-0034641963 10.1038/35037717
99. Bau D.-T., Chang C.-H., Tsai M.-H., Chiu C.-F., Tsou Y.-A., Wang R.-F., Tsai C.-W., Tsai R.-Y., Association between DNA repair gene ATM polymorphisms and oral cancer susceptibility. Laryngoscope 2010 120 12 2417 2422 2-s2.0-78649652826 10.1002/lary.21009
100. Ai L., Vo Q. N., Zuo C., Li L., Ling W., Suen J. Y., Hanna E., Brown K. D., Fan C.-Y., Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiology Biomarkers and Prevention 2004 13 1 150 156 2-s2.0-1642568676 10.1158/1055-9965.EPI-082-3 (Pubitemid 38116634)
101. Rigi-Ladiz M. A., Kordi-Tamandani D. M., Torkamanzehi A., Analysis of hypermethylation and expression profiles of APC and ATM genes in patients with oral squamous cell carcinoma. Clinical Epigenetics 2011 3 1, article 6 10.1186/1868-7083-3-6
102. Spyridonidou S., Yapijakis C., Nkenke E., Toyoshima T., Vylliotis A., Serefoglou Z., Neukam F. W., Patsouris E., Vairaktaris E., A common 9 bp deletion in the ataxia-telangiectasia-mutated gene is not associated with oral cancer. Anticancer Research 2009 29 8 3191 3193 2-s2.0-68549135067
103. Lynch H. T., Smyrk T., Hereditary nonpolyposis colorectal (Lynch syndrome): an updated review. Cancer 1996 78 6 1149 1167 (Pubitemid 26303880)
104. Wang Y., Irish J., MacMillan C., Brown D., Xuan Y., Boyington C., Gullane P., Kamel-Reid S., High frequency of microsatellite instability in young patients with head-and-neck squamous-cell carcinoma: lack of involvement of the mismatch repair genes hMLH1 and hMSH2. International Journal of Cancer 2001 93 3 353 360 2-s2.0-0035427055 10.1002/ijc.1337 (Pubitemid 32592053)
105. Piccinin S., Gasparotto D., Vukosavljevic T., Barzan L., Sulfaro S., Maestro R., Boiocchi M., Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena. British Journal of Cancer 1998 78 9 1147 1151 2-s2.0-0031724076 (Pubitemid 28479141)
106. Blons H., Cabelguenne A., Carnot F., Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma. International Journal of Cancer 1999 84 4 410 415 (Pubitemid 29337129)
107. Arzimanoglou I. I., Gilbert F., Barber H. R. K., Microsatellite instability in human solid tumors. Cancer 1998 82 10 1808 1820 (Pubitemid 28208635)
108. El-Naggar A. K., Hurr K., Huff V., Clayman G. L., Luna M. A., Batsakis J. G., Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. The American Journal of Pathology 1996 148 6 2067 2072 2-s2.0-0030008882 (Pubitemid 26170529)
109. Ishwad C. S., Ferrell R. E., Rossie K. M., Appel B. N., Johnson J. T., Myers E. N., Law J. C., Srivastava S., Gollin S. M., Microsatellite instability in oral cancer. International Journal of Cancer 1995 64 5 332 335 2-s2.0-0028793638 10.1002/ijc.2910640509
110. Ha P. K., Pilkington T. A., Westra W. H., Sciubba J., Sidransky D., Califano J. A., Progression of microsatellite instability from premalignant lesions to tumors of the head and neck. International Journal of Cancer 2002 102 6 615 617 2-s2.0-0037146756 10.1002/ijc.10748 (Pubitemid 35334469)
111. Zuo C., Zhang H., Spencer H. J., Vural E., Suen J. Y., Schichman S. A., Smoller B. R., Kokoska M. S., Fan C.-Y., Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Otolaryngology-Head and Neck Surgery 2009 141 4 484 490 2-s2.0-70349336146 10.1016/j.otohns.2009.07.007
112. González-Ramírez I., Ramírez-Amador V., Irigoyen-Camacho M. E., hMLH1 promoter methylation is an early event in oral cancer. Oral Oncology 2011 47 1 22 26 10.1016/j.oraloncology.2010.10.002
113. Viswanathan M., Tsuchida N., Shanmugam G., Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. International Journal of Cancer 2003 105 1 41 46 2-s2.0-0345269743 10.1002/ijc.11028 (Pubitemid 36418483)
114. Czerninski R., Krichevsky S., Ashhab Y., Gazit D., Patel V., Ben-Yehuda D., Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Diseases 2009 15 3 206 213 2-s2.0-62749188773 10.1111/j.1601-0825.2008.01510.x
115. Steinmann K., Sandner A., Schagdarsurengin U., Dammann R. H., Dammann R. H., Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncology Reports 2009 22 6 1519 1526 2-s2.0-70449419902 10.3892/or-00000596
116. Theocharis S., Klijanienko J., Giaginis C., Rodriguez J., Jouffroy T., Girod A., Point D., Tsourouflis G., Sastre-Garau X., Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. Journal of Oral Pathology and Medicine 2011 40 3 218 226 2-s2.0-79951877583 10.1111/j.1600-0714.2010.00945.x
117. Dou H., Mitra S., Hazra T. K., Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2. Journal of Biological Chemistry 2003 278 50 49679 49684 2-s2.0-0347379928 10.1074/jbc.M308658200 (Pubitemid 37548799)
118. Kumar A., Pant M. C., Singh H. S., Khandelwal S., Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India. Tumor Biology 2012 33 1 111 119 2-s2.0-83655184635 10.1007/s13277-011-0253-7
119. Paz-Elizur T., Ben-Yosef R., Elinger D., Vexler A., Krupsky M., Berrebi A., Shani A., Schechtman E., Freedman L., Livneh Z., Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer. Cancer Research 2006 66 24 11683 11689 2-s2.0-33846254125 10.1158/0008-5472.CAN-06-2294 (Pubitemid 46094180)
120. Mahjabeen I., Baig R. M., Sabir M., Kayani M. A., Genetic and expressional variations of APEX1 are associated with increased risk of head and neck cancer. Mutagenesis 2013 28 2 213 218 10.1093/mutage/ges074
121. Das A., Wiederhold L., Leppard J. B., Kedar P., Prasad R., Wang H., Boldogh I., Karimi-Busheri F., Weinfeld M., Tomkinson A. E., Wilson S. H., Mitra S., Hazra T. K., NEIL2-initiated, APE-independent repair of oxidized bases in DNA: evidence for a repair complex in human cells. DNA Repair 2006 5 12 1439 1448 2-s2.0-33751102395 10.1016/j.dnarep.2006.07.003 (Pubitemid 44768083)
122. Zhai X., Zhao H., Liu Z., Wang L.-E., El-Naggar A. K., Sturgis E. M., Wei Q., Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx. Clinical Cancer Research 2008 14 13 4345 4352 2-s2.0-48249153852 10.1158/1078-0432.CCR-07-5282
123. Caldecott K. W., XRCC1 and DNA strand break repair. DNA Repair 2003 2 9 955 969 2-s2.0-0041378046 10.1016/S1568-7864(03)00118-6 (Pubitemid 37088158)
124. Dunphy E. J., Beckett M. A., Thompson L. H., Weichselbaum R. R., Expression of the polymorphic human DNA repair gene XRCC1 does not correlate with radiosensitivity in the cells of human head and neck tumor cell lines. Radiation Research 1992 130 2 166 170 2-s2.0-0026729644 10.2307/3578273
125. Nix P., Greenman J., Stafford N., Cawkwell L., Expression of XRCC1 and ERCC1 proteins in radioresistant and radiosensitive laryngeal cancer. Cancer Therapy 2004 2 47 53
126. Ang M.-K., Patel M. R., Yin X.-Y., Sundaram S., Fritchie K., Zhao N., Liu Y., Freemerman A. J., Wilkerson M. D., Walter V., Weissler M. C., Shockley W. W., Couch M. E., Zanation A. M., Hackman T., Chera B. S., Harris S. L., Miller C. R., Thorne L. B., Hayward M. C., Funkhouser W. K., Olshan A. F., Shores C. G., Makowski L., Hayes D. N., High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma. Clinical Cancer Research 2011 17 20 6542 6552 2-s2.0-80054118265 10.1158/1078-0432.CCR- 10-1604
127. Sousa F. G., Matuo R., Soares D., Escargueil A. E., Henriques J. A. P., Larsen A. K., Saffi J., PARPs and the DNA damage response. Carcinogenesis 2012 33 8 1433 1440
128. Sugimura K., Takebayashi S.-I., Taguchi H., Takeda S., Okumura K., PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA. Journal of Cell Biology 2008 183 7 1203 1212 2-s2.0-59449101071 10.1083/jcb.200806068
129. Schultz N., Lopez E., Saleh-Gohari N., Helleday T., Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination. Nucleic Acids Research 2003 31 17 4959 4964 2-s2.0-0344875495 10.1093/nar/gkg703 (Pubitemid 37441861)
130. de Vos M., Schreiber V., Dantzer F., The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochemical Pharmacology 2012 84 2 137 146 2-s2.0-84859806890 10.1016/j.bcp.2012.03.018
131. Schreiber V., Amé J.-C., Dollé P., Schultz I., Rinaldi B., Fraulob V., Ménissier-de Murcia J., De Murcia G., Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. Journal of Biological Chemistry 2002 277 25 23028 23036 2-s2.0-0037151051 10.1074/jbc.M202390200 (Pubitemid 34967289)
132. Bryant H. E., Schultz N., Thomas H. D., Parker K. M., Flower D., Lopez E., Kyle S., Meuth M., Curtin N. J., Helleday T., Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005 434 7035 913 917 2-s2.0-17244375049 10.1038/nature03443 (Pubitemid 40559005)
133. Fong P. C., Boss D. S., Yap T. A., Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. The New England Journal of Medicine 2009 361 2 123 134 10.1056/NEJMoa0900212
134. Nowsheen S., Bonner J. A., LoBuglio A. F., Trummell H., Whitley A. C., Dobelbower M. C., Yang E. S., Cetuximab augments cytotoxicity with poly (ADP-Ribose) polymerase inhibition in head and neck cancer. PLoS ONE 2011 6 8 2-s2.0-80052288059 10.1371/journal.pone.0024148 e24148
135. Abuzeid W. M., Khan K., Jiang X., Cao X., O'Malley B. W. Jr., Li D., R013: disruption of DNA damage signaling: a novel therapy for HNSCC. Otolaryngology-Head and Neck Surgery 2007 137 2, supplement P152 P153
136. Tanaka T., Munshi A., Brooks C., Liu J., Hobbs M. L., Meyn R. E., Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity. Clinical Cancer Research 2008 14 4 1266 1273 2-s2.0-39749129748 10.1158/1078-0432.CCR-07-1606 (Pubitemid 351302576)
137. McCabe N., Turner N. C., Lord C. J., Kluzek K., Białkowska A., Swift S., Giavara S., O'Connor M. J., Tutt A. N., Zdzienicka M. Z., Smith G. C. M., Ashworth A., Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Research 2006 66 16 8109 8115 2-s2.0-33748065304 10.1158/0008-5472.CAN-06-0140 (Pubitemid 44299177)
138. Ibrahim Y. H., García-García C., Serra V., PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. Cancer Discovery 2012 2 11 1036 1047
139. Yamashita T., Miyamoto S., O'Malley B., Li D., The role of PARP 1 for cisplatin-based chemoresistance. Otolaryngology-Head and Neck Surgery 2010 143 2, supplement P54
140. Wang L.-E., Sturgis E. M., Eicher S. A., Spitz M. R., Hong W. K., Wei Q., Mutagen sensitivity to Benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clinical Cancer Research 1998 4 7 1773 1778 2-s2.0-0031798672 (Pubitemid 28304741)
141. Robu M., Shah R. G., Petitclerc N., Brind'Amour J., Kandan-Kulangara F., Shah G. M., Role of poly(ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair. Proceedings of the National Academy of Sciences of the United States of America 2013 110 5 1658 1663 10.1073/pnas.1209507110
142. Shuck S. C., Short E. A., Turchi J. J., Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Research 2008 18 1 64 72 2-s2.0-38049164275 10.1038/cr.2008.2
143. Cleaver J. E., Photosensitivity syndrome brings to light a new transcription-coupled DNA repair cofactor. Nature Genetics 2012 44 5 477 478 2-s2.0-84860340909 10.1038/ng.2255
144. Wei L., Lan L., Yasui A., Tanaka K., Saijo M., Matsuzawa A., Kashiwagi R., Maseki E., Hu Y., Parvin J. D., Ishioka C., Chiba N., BRCA1 contributes to transcription-coupled repair of DNA damage through polyubiquitination and degradation of Cockayne syndrome B protein. Cancer Science 2011 102 10 1840 1847 2-s2.0-80053386690 10.1111/j.1349-7006.2011.02037.x
145. Kamenisch Y., Berneburg M., Progeroid syndromes and UV-induced oxidative DNA damage. Journal of Investigative Dermatology Symposium Proceedings 2009 14 1 8 14 2-s2.0-68849091521 10.1038/jidsymp.2009.6
146. Wijnhoven S. W. P., Kool H. J. M., Van Oostrom C. T. M., Beems R. B., Mullenders L. H. F., Van Zeeland A. A., Van der Horst G. T. J., Vrieling H., Van Steeg H., The relationship between benzo[a]pyrene-induce mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice. Cancer Research 2000 60 20 5681 5687 2-s2.0-0034667416
147. Chiu T.-J., Chen C.-H., Chien C.-Y., Li S.-H., Tsai H.-T., Chen Y.-J., High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area. Journal of Translational Medicine 2011 9, article 31 2-s2.0-79953089755 10.1186/1479-5876-9-31
148. Handra-Luca A., Hernandez J., Mountzios G., Taranchon E., Lacau-St-Guily J., Soria J.-C., Fouret P., Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma. Clinical Cancer Research 2007 13 13 3855 3859 2-s2.0-34447126864 10.1158/1078-0432.CCR-07-0252 (Pubitemid 47037591)
149. Jun H. J., Ahn M. J., Kim H. S., Yi S. Y., Han J., Lee S. K., Ahn Y. C., Jeong H.-S., Son Y.-I., Baek J.-H., Park K., ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. British Journal of Cancer 2008 99 1 167 172 2-s2.0-46349110628 10.1038/sj.bjc.6604464 (Pubitemid 351920246)
150. Tsai L. L., Yu C., Lo J.-F., Enhanced cisplatin resistance in oral-cancer stem-like cells is correlated with upregulation of excision-repair cross-complementation group 1. Journal of Dental Sciences 2012 7 2 111 117
151. Ahmad A., Robinson A. R., Duensing A., Van Drunen E., Beverloo H. B., Weisberg D. B., Hasty P., Hoeijmakers J. H. J., Niedernhofer L. J., ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Molecular and Cellular Biology 2008 28 16 5082 5092 2-s2.0-49449084673 10.1128/MCB.00293-08
152. Köberle B., Ditz C., Kausch I., Wollenberg B., Ferris R. L., Albers A. E., Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo. International Journal of Oncology 2010 36 5 1277 1284 2-s2.0-77950450824 10.3892/ijo-00000612
153. Wang Y., Spitz M. R., Lee J. J., Huang M., Lippman S. M., Wu X., Nucleotide excision repair pathway genes and oral premalignant lesions. Clinical Cancer Research 2007 13 12 3753 3758 2-s2.0-34250722756 10.1158/1078-0432.CCR- 06-1911 (Pubitemid 46955141)
154. Cheng L., Sturgis E. M., Eicher S. A., Spitz M. R., Wei Q., Expression of nucleotide excision repair genes and dhe risk for squamous cell carcinoma of the head and neck. Cancer 2002 94 2 393 397 2-s2.0-0037080448 10.1002/cncr.10231 (Pubitemid 34081368)
155. Yu H., Liu Z., Huang Y. J., Yin M., Wang L. E., Wei Q., Association between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neck. PLoS ONE 2012 7 7 10.1371/journal.pone.0041853 e41853
156. Sliwinski T., Markiewicz L., Rusin P., Kabzinski J., Dziki L., Milonski J., Olszewski J., Blaszczyk J., Szemraj J., Majsterek I., Impaired nucleotide excision repair pathway as a possible factor in pathogenesis of head and neck cancer. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 2011 716 1-2 51 58 2-s2.0-80053573238 10.1016/j.mrfmmm.2011.08.002
157. Zafereo M. E., Sturgis E., Wei Q., Li G., Liu Z., Wang L., Nucleotide excision repair and risk of second primary cancer. Otolaryngology-Head and Neck Surgery 2009 141 3, supplement 1 P55 P56
158. Roberts S. A., Strande N., Burkhalter M. D., Strom C., Havener J. M., Hasty P., Ramsden D. A., Ku is a 5′-dRP/AP lyase that excises nucleotide damage near broken ends. Nature 2010 464 7292 1214 1217 2-s2.0-77951621112 10.1038/nature08926
159. Indiviglio S. M., Bertuch A. A., Ku's essential role in keeping telomeres intact. Proceedings of the National Academy of Sciences of the United States of America 2009 106 30 12217 12218 2-s2.0-68149112623 10.1073/pnas.0906427106
160. Moeller B. J., Yordy J. S., Williams M. D., Giri U., Raju U., Molkentine D. P., Byers L. A., Heymach J. V., Story M. D., Lee J. J., Sturgis E. M., Weber R. S., Garden A. S., Ang K. K., Schwartz D. L., DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. Clinical Cancer Research 2011 17 7 2035 2043 2-s2.0-79953306841 10.1158/1078-0432.CCR-10-2641
161. Pavón M. A., Parreño M., León X., Sancho F. J., Céspedes M. V., Casanova I., Lopez-Pousa A., Mangues M. A., Quer M., Barnadas A., Mangues R., Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. International Journal of Cancer 2008 123 5 1068 1079 2-s2.0-47249095810 10.1002/ijc.23635
162. Friesland S., Kanter-Lewensohn L., Tell R., Munck-Wikland E., Lewensohn R., Nilsson A., Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy. Head and Neck 2003 25 4 313 321 2-s2.0-0037379412 10.1002/hed.10199 (Pubitemid 36368683)
163. Sonoda E., Hochegger H., Saberi A., Taniguchi Y., Takeda S., Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair 2006 5 9-10 1021 1029 2-s2.0-33747889217 10.1016/j.dnarep.2006.05.022 (Pubitemid 44291617)
164. D'Andrea A. D., Grompe M., The fanconi anaemia/BRCA pathway. Nature Reviews Cancer 2003 3 1 23 34 2-s2.0-0037268338 10.1038/nrc970 (Pubitemid 37328884)
165. Rosenberg P. S., Greene M. H., Alter B. P., Cancer incidence in persons with Fanconi anemia. Blood 2003 101 3 822 826 2-s2.0-0037306904 10.1182/blood-2002-05-1498 (Pubitemid 36139345)
166. Wreesmann V. B., Estilo C., Eisele D. W., Singh B., Wang S. J., Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma. Journal for Oto-Rhino-Laryngology and Its Related Specialties 2007 69 4 218 225 2-s2.0-34250658382 10.1159/000101542 (Pubitemid 46934196)
167. Tremblay S., dos Reis P. P., Bradley G., Galloni N. N., Perez-Ordonez B., Freeman J., Brown D., Gilbert R., Gullane P., Irish J., Kamel-Reid S., Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes. Archives of Otolaryngology-Head and Neck Surgery 2006 132 9 958 966 2-s2.0-33748881426 10.1001/archotol.132.9. 958 (Pubitemid 44423378)
168. Hays L. E., Zodrow D. M., Yates J. E., Deffebach M. E., Jacoby D. B., Olson S. B., Pankow J. F., Bagby G. C., Cigarette smoke induces genetic instability in airway epithelial cells by suppressing FANCD2 expression. British Journal of Cancer 2008 98 10 1653 1661 2-s2.0-43649107543 10.1038/sj.bjc. 6604362 (Pubitemid 351684688)
169. Marsit C. J., Liu M., Nelson H. H., Posner M., Suzuki M., Kelsey K. T., Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 2004 23 4 1000 1004 2-s2.0-1342301467 10.1038/sj.onc.1207256 (Pubitemid 38250946)
170. Ghosh A., Ghosh S., Maiti G. P., Mukherjee S., Mukherjee N., Chakraborty J., Roy A., Roychoudhury S., Panda C. K., Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck. Annals of Surgical Oncology 2012 19 supplement 3 S528 S538 2-s2.0-80051795732 10.1245/s10434-011-1991-x
171. Smith I. M., Mithani S. K., Mydlarz W. K., Chang S. S., Califano J. A., Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers. Journal for Oto-Rhino-Laryngology and Its Related Specialties 2010 72 1 44 50 2-s2.0-77949545721 10.1159/000292104
172. Snyder E. R., Ricker J. L., Chen Z., Waes C. V., Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines. Cancer Letters 2007 245 1-2 75 80 2-s2.0-33845652128 10.1016/j.canlet.2005.12.028 (Pubitemid 44959341)
173. Manthey K. C., Glanzer J. G., Dimitrova D. D., Oakley G. G., Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines. Head and Neck 2010 32 5 636 645 2-s2.0-77951539333 10.1002/hed.21234
174. Thompson D., Easton D. F., The Breast Cancer Linkage Consortium, Cancer incidence in BRCA1 mutation carriers. Journal of the National Cancer Institute 2002 94 18 1358 1365 2-s2.0-0037130887 (Pubitemid 35154140)
175. Ford D., Easton D. F., Bishop D. T., Narod S. A., Goldgar D. E., Risks of cancer in BRCA1-mutation carriers. The Lancet 1994 343 8899 692 695 2-s2.0-0028330276 10.1016/S0140-6736(94)91578-4 (Pubitemid 24087847)
176. Taron M., Rosell R., Felip E., Mendez P., Souglakos J., Ronco M. S., Queralt C., Majo J., Sanchez J. M., Sanchez J. J., Maestre J., BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer. Human Molecular Genetics 2004 13 20 2443 2449 2-s2.0-19544379515 10.1093/hmg/ddh260 (Pubitemid 39377848)
177. Tobin L. A., Robert C., Nagaria P., Chumsri S., Twaddell W., Ioffe O. B., Greco G. E., Brodie A. H., Tomkinson A. E., Rassool F. V., Targeting abnormal DNA repair in therapy-resistant breast cancers. Molecular Cancer Research 2012 10 1 96 107 2-s2.0-84856021931 10.1158/1541-7786.MCR-11-0255
178. Vora H. H., Shah N. G., Patel D. D., Trivedi T. I., Choksi T. J., BRCA1 expression in leukoplakia and carcinoma of the tongue. Journal of Surgical Oncology 2003 83 4 232 240 2-s2.0-0043211844 10.1002/jso.10213 (Pubitemid 36936009)
179. Nawroz-Danish H. M., Koch W. M., Westra W. H., Yoo G., Sidransky D., Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma. Otolaryngology-Head and Neck Surgery 1998 119 1 21 25 2-s2.0-0031829527 10.1016/S0194-5998(98)70168-8 (Pubitemid 28350660)
180. Kolch W., Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochemical Journal 2000 351 2 289 305 2-s2.0-0034667593 10.1042/0264-6021:3510289
181. Marshall C. J., Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995 80 2 179 185 2-s2.0-0028872649
182. Lui V. W., Hedberg M. L., Li H., Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discovery 2013 3 7 761 769 10.1158/2159-8290.CD-13-0103
183. Toulany M., Kasten-Pisula U., Brammer I., Wang S., Chen J., Dittmann K., Baumann M., Dikomey E., Rodemann H. P., Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair. Clinical Cancer Research 2006 12 13 4119 4126 2-s2.0-33746088022 10.1158/1078-0432.CCR- 05-2454 (Pubitemid 44078101)
184. Huang S.-M., Bock J. M., Harari P. M., Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Research 1999 59 8 1935 1940 2-s2.0-0033561522 (Pubitemid 29186168)
185. Kumar A., Fernadez-Capetillo O., Carrera A. C., Nuclear phosphoinositide 3-kinase β controls double-strand break DNA repair. Proceedings of the National Academy of Sciences of the United States of America 2010 107 16 7491 7496 2-s2.0-77952146825 10.1073/pnas.0914242107
186. Kao G. D., Jiang Z., Fernandes A. M., Gupta A. K., Maity A., Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. Journal of Biological Chemistry 2007 282 29 21206 21212 2-s2.0-34547114987 10.1074/jbc.M703042200 (Pubitemid 47099899)
187. Toulany M., Kehlbach R., Florczak U., Sak A., Wang S., Chen J., Lobrich M., Rodemann H. P., Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Molecular Cancer Therapeutics 2008 7 7 1772 1781 2-s2.0-51049105757 10.1158/1535-7163.MCT-07-2200
188. Plo I., Laulier C., Gauthier L., Lebrun F., Calvo F., Lopez B. S., AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD5. Cancer Research 2008 68 22 9404 9412 2-s2.0-56449128931 10.1158/0008-5472.CAN-08-0861
189. Li L., Wang H., Yang E. S., Arteaga C. L., Xia F., Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells. Cancer Research 2008 68 22 9141 9146 2-s2.0-56449098784 10.1158/0008-5472.CAN-08-1127
190. Chinnaiyan P., Huang S., Vallabhaneni G., Armstrong E., Varambally S., Tomlins S. A., Chinnaiyan A. M., Harari P. M., Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva). Cancer Research 2005 65 8 3328 3335 2-s2.0-17144371349 (Pubitemid 40524617)
191. Engelman J. A., Jänne P. A., Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Clinical Cancer Research 2008 14 10 2895 2899 2-s2.0-49649127657 10.1158/1078-0432.CCR-07-2248
192. Lynch T. J., Bell D. W., Sordella R., Gurubhagavatula S., Okimoto R. A., Brannigan B. W., Harris P. L., Haserlat S. M., Supko J. G., Haluska F. G., Louis D. N., Christiani D. C., Settleman J., Haber D. A., Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. The New England Journal of Medicine 2004 350 21 2129 2139 2-s2.0-2342471392 10.1056/NEJMoa040938 (Pubitemid 38637993)
193. Loeffler-Ragg J., Witsch-Baumgartner M., Tzankov A., Hilbe W., Schwentner I., Sprinzl G. M., Utermann G., Zwierzina H., Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma. European Journal of Cancer 2006 42 1 109 111 2-s2.0-29144520704 10.1016/j.ejca.2005.08.034 (Pubitemid 41814540)
194. Lee J. W., Soung Y. H., Kim S. Y., Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clinical Cancer Research 2005 11 8 2879 2882 2-s2.0-20244389231 10.1158/1078-0432.CCR-04-2029 (Pubitemid 40525187)
195. Schwentner I., Witsch-Baumgartner M., Sprinzl G. M., Krugmann J., Tzankov A., Jank S., Zwierzina H., Loeffler-Ragg J., Identification of the rare EGFR mutation p.G796S as somatic and germline mutation in white patients with squamous cell carcinoma of the head and neck. Head and Neck 2008 30 8 1040 1044 2-s2.0-50249148896 10.1002/hed.20831
196. Na I. I., Kang H. J., Cho S. Y., Koh J. S., Lee J. K., Lee B. C., Lee G. H., Lee Y. S., Yoo H. J., Ryoo B.-Y., Yang S. H., Shim Y. S., EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil. European Journal of Cancer 2007 43 3 520 526 2-s2.0-33846609066 10.1016/j.ejca.2006.09. 025 (Pubitemid 46177596)
197. Ali M. A. L. S., Gunduz M., Nagatsuka H., Gunduz E., Cengiz B., Fukushima K., Beder L. B., Demircan K., Fujii M., Yamanaka N., Shimizu K., Grenman R., Nagai N., Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. Cancer Science 2008 99 8 1589 1594 2-s2.0-49749113623 10.1111/j.1349-7006.2008.00861.x
198. Sok J. C., Coppelli F. M., Thomas S. M., Lango M. N., Xi S., Hunt J. L., Freilino M. L., Graner M. W., Wikstrand C. J., Bigner D. D., Gooding W. E., Furnari F. B., Grandis J. R., Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clinical Cancer Research 2006 12 17 5064 5073 2-s2.0-33749035470 10.1158/1078-0432.CCR-06-0913 (Pubitemid 44453332)
199. Gan H. K., Kaye A. H., Luwor R. B., The EGFRvIII variant in glioblastoma multiforme. Journal of Clinical Neuroscience 2009 16 6 748 754 2-s2.0-67349137902 10.1016/j.jocn.2008.12.005
200. Wheeler S. E., Suzuki S., Thomas S. M., Sen M., Leeman-Neill R. J., Chiosea S. I., Kuan C.-T., Bigner D. D., Gooding W. E., Lai S. Y., Grandis J. R., Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene 2010 29 37 5135 5145 2-s2.0-77956941983 10.1038/onc.2009.279
201. Batra S. K., Castelino-Prabhu S., Wikstrand C. J., Zhu X., Humphrey P. A., Friedman H. S., Bigner D. D., Epidermal growth factor ligand-independent, unregulated, cell- transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth and Differentiation 1995 6 10 1251 1259 2-s2.0-0028863853
202. Murugan A. K., Thi Hong N., Fukui Y., Munirajan A. K., Tsuchida N., Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas. International Journal of Oncology 2008 32 1 101 111 2-s2.0-38749116169 (Pubitemid 351176067)
203. Qiu W., Schönleben F., Li X., Ho D. J., Close L. G., Manolidis S., Bennett B. P., Su G. H., PIK3CA mutations in head and neck squamous cell carcinoma. Clinical Cancer Research 2006 12 5 1441 1446 2-s2.0-33645084781 10.1158/1078-0432.CCR-05-2173
204. Fenic I., Steger K., Gruber C., Arens C., Woenckhaus J., Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma. Oncology Reports 2007 18 1 253 259 2-s2.0-34548048411
205. Cohen Y., Goldenberg-Cohen N., Shalmon B., Shani T., Oren S., Amariglio N., Dratviman-Storobinsky O., Shnaiderman-Shapiro A., Yahalom R., Kaplan I., Hirshberg A., Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma. Oral Oncology 2011 47 10 946 950 2-s2.0-80054001986 10.1016/j.oraloncology.2011.07.013
206. Ongkeko W. M., Altuna X., Weisman R. A., Wang-Rodriguez J., Expression of protein tyrosine kinases in head and neck squamous cell carcinomas. American Journal of Clinical Pathology 2005 124 1 71 76 2-s2.0-21744437097 10.1309/BTLN-5WTM-J3PC-NRRC (Pubitemid 40944376)
207. Grandis J. R., Melhem M. F., Gooding W. E., Day R., Holst V. A., Wagener M. M., Drenning S. D., Tweardy D. J., Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. Journal of the National Cancer Institute 1998 90 11 824 832 2-s2.0-0032478998 (Pubitemid 28280548)
208. Ang K. K., Berkey B. A., Tu X., Zhang H.-Z., Katz R., Hammond E. H., Fu K. K., Milas L., Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Research 2002 62 24 7350 7356 2-s2.0-0037115674 (Pubitemid 36025259)
209. Huang S.-F., Chuang W.-Y., Chen I.-H., Liao C.-T., Wang H.-M., Hsieh L.-L., EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan. Head and Neck 2009 31 8 1068 1077 2-s2.0-67650418218 10.1002/hed.21067
210. Abhold E. L., Kiang A., Rahimy E., Kuo S. Z., Wang-Rodriguez J., Lopez J. P., Blair K. J., Yu M. A., Haas M., Brumund K. T., Altuna X., Patel A., Weisman R. A., Ongkeko W. M., EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells. PLoS ONE 2012 7 2 2-s2.0-84857510274 10.1371/journal.pone. 0032459 e32459
211. Temam S., Kawaguchi H., El-Naggar A. K., Jelinek J., Tang H., Liu D. D., Lang W., Issa J.-P., Lee J. J., Mao L., Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. Journal of Clinical Oncology 2007 25 16 2164 2170 2-s2.0-34250155320 10.1200/JCO.2006.06.6605 (Pubitemid 46954638)
212. Morrison L. E., Jacobson K. K., Friedman M., Schroeder J. W., Coon J. S., Aberrant EGFR and chromosome 7 associate with outcome in laryngeal cancer. Laryngoscope 2005 115 7 1212 1218 2-s2.0-21844460791 10.1097/01.MLG.0000163755. 21035.8F (Pubitemid 40962358)
213. Bonner J. A., Harari P. M., Giralt J., Azarnia N., Shin D. M., Cohen R. B., Jones C. U., Sur R., Raben D., Jassem J., Ove R., Kies M. S., Baselga J., Youssoufian H., Amellal N., Rowinsky E. K., Ang K. K., Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. The New England Journal of Medicine 2006 354 6 567 578 2-s2.0-32144433159 10.1056/NEJMoa053422 (Pubitemid 43209104)
214. National Comprehensive Cancer Network. Head and Neck Cancers 2012. http://www.nccn.org/professionals/physician-gls/pdf/head-and-neck.pdf
215. Ko J.-C., Ciou S.-C., Cheng C.-M., Wang L.-H., Hong J.-H., Jheng M.-Y., Ling S.-T., Lin Y.-W., Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, Iressa R) and chemotherapeutic agents in human lung cancer cells. Carcinogenesis 2008 29 7 1448 1458 2-s2.0-49349094037 10.1093/carcin/bgn130
216. Stewart J. S., Cohen E. E., Licitra L., Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck. Journal of Clinical Oncology 2009 27 11 1864 1871 10.1200/JCO.2008.17.0530
217. Bentzen S. M., Atasoy B. M., Daley F. M., Dische S., Richman P. I., Saunders M. I., Trott K. R., Wilson G. D., Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. Journal of Clinical Oncology 2005 23 24 5560 5567 2-s2.0-24944479590 10.1200/JCO.2005.06.411
218. Chen D. J., Nirodi C. S., The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clinical Cancer Research 2007 13 22 6555 6560 2-s2.0-36749008023 10.1158/1078-0432.CCR-07-1610 (Pubitemid 350206788)
219. Li C., Iida M., Dunn E. F., Ghia A. J., Wheeler D. L., Nuclear EGFR contributes to acquired resistance to cetuximab. Oncogene 2009 28 43 3801 3813 2-s2.0-70350653741 10.1038/onc.2009.234
220. Wheeler D. L., Huang S., Kruser T. J., Nechrebecki M. M., Armstrong E. A., Benavente S., Gondi V., Hsu K.-T., Harari P. M., Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members. Oncogene 2008 27 28 3944 3956 2-s2.0-46249087766 10.1038/onc.2008.19 (Pubitemid 351913636)
221. Misale S., Yaeger R., Hobor S., Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 2012 486 7404 532 536 10.1038/nature11156
222. Frazer K. A., Ballinger D. G., Cox D. R., A second generation human haplotype map of over 3.1 million SNPs. Nature 2007 449 7164 851 861 (Pubitemid 47598626)
223. Mahjabeen I., Baig R. M., Masood N., Sabir M., Malik F. A., Kayani M. A., OGG1 gene sequence variation in head and neck cancer patients in pakistan. Asian Pacific Journal of Cancer Prevention 2011 12 10 2779 2783 2-s2.0-84858234460
224. Hashimoto T., Uchida K., Okayama N., Imate Y., Suehiro Y., Hamanaka Y., Ueyama Y., Yamashita H., Hinoda Y., Interaction of OGG1 Ser326Cys polymorphism with cigarette smoking in head and neck squamous cell carcinoma. Molecular Carcinogenesis 2006 45 5 344 348 2-s2.0-33646730157 10.1002/mc.20140
225. Majumder M., Indra D., Roy P. D., Datta S., Ray J. G., Panda C. K., Roy B., Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples. Journal of Oral Pathology and Medicine 2009 38 2 174 180 2-s2.0-58449109417 10.1111/j.1600-0714.2008.00690.x
226. Applebaum K. M., McClean M. D., Nelson H. H., Marsit C. J., Christensen B. C., Kelsey K. T., Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. International Journal of Cancer 2009 124 11 2690 2696 2-s2.0-64249103041 10.1002/ijc.24256
227. Huang J., Ye F., Chen H., Lu W., Xie X., The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection. International Journal of Gynecological Cancer 2007 17 3 668 675 2-s2.0-34248394239 10.1111/j.1525-1438.2007.00840.x (Pubitemid 46744005)
228. Kumar A., Pant M. C., Singh H. S., Khandelwal S., Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 2012 729 1-2 24 34 2-s2.0-83555162511 10.1016/j.mrfmmm.2011.09.001
229. Carles J., Monzo M., Amat M., Jansa S., Artells R., Navarro A., Foro P., Alameda F., Gayete A., Gel B., Miguel M., Albanell J., Fabregat X., Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 2006 66 4 1022 1030 2-s2.0-33750324135 10.1016/j.ijrobp.2006.06.029 (Pubitemid 44633517)
230. De Castro G. Jr., Pasini F. S., Siqueira S. A. C., Ferraz A. R., Villar R. C., Snitcovsky I. M. L., Federico M. H. H., ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation. Oncology Reports 2011 25 3 693 699 2-s2.0-79551590004 10.3892/or.2011.1133
231. Swift M., Morrell D., Massey R. B., Chase C. L., Incidence of cancer in 161 families affected by ataxia-telangiectasia. The New England Journal of Medicine 1991 325 26 1831 1836 2-s2.0-0026409331
232. Sung P., Klein H., Mechanism of homologous recombination: mediators and helicases take on regulatory functions. Nature Reviews Molecular Cell Biology 2006 7 10 739 750 2-s2.0-33749037701 10.1038/nrm2008 (Pubitemid 44450458)
233. Richard D. J., Bolderson E., Cubeddu L., Wadsworth R. I. M., Savage K., Sharma G. G., Nicolette M. L., Tsvetanov S., McIlwraith M. J., Pandita R. K., Takeda S., Hay R. T., Gautier J., West S. C., Paull T. T., Pandita T. K., White M. F., Khanna K. K., Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature 2008 453 7195 677 681 2-s2.0-44449118949 10.1038/nature06883 (Pubitemid 351769294)
234. Richard D. J., Savage K., Bolderson E., Cubeddu L., So S., Ghita M., Chen D. J., White M. F., Richard K., Prise K. M., Schettino G., Khanna K. K., HSSB1 rapidly binds at the sites of DNA double-strand breaks and is required for the efficient recruitment of the MRN complex. Nucleic Acids Research 2011 39 5 1692 1702 2-s2.0-79952233616 10.1093/nar/gkq1098
235. Nakada S., Yonamine R. M., Matsuo K., RNF8 regulates assembly of RAD51 at DNA double-strand breaks in the absence of BRCA1 and 53BP1. Cancer Research 2012 72 19 4974 4983
236. Bolderson E., Tomimatsu N., Richard D. J., Boucher D., Kumar R., Pandita T. K., Burma S., Khanna K. K., Phosphorylation of Exo1 modulates homologous
237. Richard D. J., Cubeddu L., Urquhart A. J., Bain A., Bolderson E., Menon D., White M. F., Khanna K. K., hSSB1 interacts directly with the MRN complex stimulating its recruitment to DNA double-strand breaks and its endo-nuclease activity. Nucleic Acids Research 2011 39 9 3643 3651 2-s2.0-79956004104 10.1093/nar/gkq1340
238. Mansour W. Y., Rhein T., Dahm-Daphi J., The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies. Nucleic Acids Research 2010 38 18 6065 6077 2-s2.0-78049446968 10.1093/nar/gkq387
239. Shinmura K., Tao H., Goto M., Igarashi H., Taniguchi T., Maekawa M., Takezaki T., Sugimura H., Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer. Carcinogenesis 2004 25 12 2311 2317 2-s2.0-10344242928 10.1093/carcin/bgh267 (Pubitemid 39625170)
240. Sliwinski T., Walczak A., Przybylowska K., Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Experimental and Molecular Pathology 2010 89 3 358 366 10.1016/j.yexmp.2010.08.005
241. Romanowicz-Makowska H., Smolarz B., Gajȩcka M., Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking-and drinking-related laryngeal cancer in a Polish population. Archives of Medical Science 2012 8 6 1065 1075
242. Werbrouck J., De Ruyck K., Duprez F., Van Eijkeren M., Rietzschel E., Bekaert S., Vral A., De Neve W., Thierens H., Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutation Research-Genetic Toxicology and Environmental Mutagenesis 2008 656 1-2 74 81 2-s2.0-53349145161 10.1016/j.mrgentox.2008.07.013
243. Cui Y., Morgenstern H., Greenland S., Tashkin D. P., Mao J., Cao W., Cozen W., Mac T. M., Zhang Z.-F., Polymorphism of xeroderma pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. International Journal of Cancer 2006 118 3 714 720 2-s2.0-30444442970 10.1002/ijc.21413 (Pubitemid 43076022)
244. dos Reis M. B., Losi-Guembarovski R., de Souza Fonseca Ribeiro E. M., Allelic variants of XRCC1 and XRCC3 repair genes and susceptibility of oral cancer in Brazilian patients. Journal of Oral Pathology & Medicine 2013 42 2 180 185
245. Pawlowska E., Janik-Papis K., Rydzanicz M., Zuk K., Kaczmarczyk D., Olszewski J., Szyfter K., Blasiak J., Morawiec-Sztandera A., The Cys326 allele of the 8-oxoguanine DNA N-glycosylase 1 gene as a risk factor in smoking- and drinking-associated larynx cancer. Tohoku Journal of Experimental Medicine 2009 219 4 269 275 2-s2.0-73849125627 10.1620/tjem.219.269
246. Kietthubthew S., Sriplung H., Au W. W., Ishida T., Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. International Journal of Hygiene and Environmental Health 2006 209 1 21 29 2-s2.0-29144447438 10.1016/j.ijheh.2005.06.002 (Pubitemid 41811255)
247. Gresner P., Gromadzinska J., Polanska K., Twardowska E., Jurewicz J., Wasowicz W., Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer. Gene 2012 504 2 166 174 10.1016/j.gene.2012.05.030
248. Zhang Z., Shi Q., Wang L.-E., Sturgis E. M., Spitz M. R., El-Naggar A. K., Hong W. K., Wei Q., No association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiology Biomarkers and Prevention 2004 13 6 1081 1083 2-s2.0-2942597642 (Pubitemid 38756722)
249. Elahi A., Zheng Z., Park J., Eyring K., McCaffrey T., Lazarus P., The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 2002 23 7 1229 1234 2-s2.0-0036322897 (Pubitemid 34814782)
250. Ramachandran S., Ramadas K., Hariharan R., Rejnish Kumar R., Radhakrishna Pillai M., Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncology 2006 42 4 350 362 2-s2.0-33645056964 10.1016/j.oraloncology.2005.08.010
251. Tae K., Lee H. S., Park B. J., Park C. W., Kim K. R., Cho H. Y., Kim L. H., Park B. L., Shin H. D., Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. International Journal of Cancer 2004 111 5 805 808 2-s2.0-4043095611 10.1002/ijc.20338 (Pubitemid 39062908)
252. Kowalski M., Przybylowska K., Rusin P., Olszewski J., Morawiec-Sztandera A., Bielecka-Kowalska A., Pietruszewska W., Mlynarski W., Szemaraj J., Majsterek I., Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. Journal of Experimental and Clinical Cancer Research 2009 28 1, article 37 2-s2.0-63149109073 10.1186/1756-9966-28-37
253. Yen C.-Y., Liu S.-Y., Chen C.-H., Tseng H.-F., Chuang L.-Y., Yang C.-H., Lin Y.-C., Wen C.-H., Chiang W.-F., Ho C.-H., Chen H.-C., Wang S.-T., Lin C.-W., Chang H.-W., Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. Journal of Oral Pathology and Medicine 2008 37 5 271 277 2-s2.0-42149086090 10.1111/j.1600-0714.2007.00608.x (Pubitemid 351533531)
254. Tseng H.-C., Tsai M.-H., Chiu C.-F., Wang C.-H., Chang N.-W., Huang C.-Y., Tsai C.-W., Liang S.-Y., Wang C.-L., Bau D.-T., Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. Anticancer Research 2008 28 3A 1687 1691 2-s2.0-45949083767 (Pubitemid 351892945)
255. Chiu C.-F., Tsai M.-H., Tseng H.-C., Wang C.-L., Wang C.-H., Wu C.-N., Lin C.-C., Bau D.-T., A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncology 2008 44 9 898 902 2-s2.0-50049107404 10.1016/j.oraloncology.2007.11.007
256. Chiu C.-F., Tsai M.-H., Tseng H.-C., Wang C.-L., Tsai F.-J., Lin C.-C., Bau D.-T., A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncology 2008 44 6 582 586 2-s2.0-43449121529 10.1016/j.oraloncology.2007.07.006 (Pubitemid 351672241)
257. Hsu C.-F., Tseng H.-C., Chiu C.-F., Liang S.-Y., Tsai C.-W., Tsai M.-H., Bau D.-T., Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility. Oral Oncology 2009 45 9 789 793 2-s2.0-68949221013 10.1016/j.oraloncology.2008.12.002
258. Bau D.-T., Tseng H.-C., Wang C.-H., Chiu C.-F., Hua C.-H., Wu C.-N., Liang S.-Y., Wang C.-L., Tsai C.-W., Tsai M.-H., Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Oral Oncology 2008 44 11 1047 1051 2-s2.0-53849128511 10.1016/j.oraloncology.2008.02.008
259. Flores-Obando R. E., Gollin S. M., Ragin C. C., Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers 2010 15 5 379 399 2-s2.0-77954840629 10.3109/13547501003797664